TaiGen Biopharmaceuticals Holdings Limited

TPEX:4157 Stock Report

Market Cap: NT$9.0b

TaiGen Biopharmaceuticals Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 4157?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders16,624,3252.32%
Institutions42,416,2265.91%
Private Companies77,711,67010.8%
Public Companies97,502,59013.6%
VC/PE Firms103,007,25914.3%
General Public380,582,10553%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 13 shareholders own 46.98% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.4%
National Development Fund, Executive Yuan
103,007,259NT$1.3b0%0.07%
13.6%
YFY Inc.
97,502,590NT$1.2b0%no data
6.11%
Taiwan Sugar Corporation
43,883,058NT$550.7m0%no data
2.89%
Yao-Hwa Glass Co., Ltd. Administration Committee
20,770,529NT$260.7m0%no data
2.84%
Sinopac Venture Capital Corporation
20,356,154NT$255.5m0%61.16%
2.32%
Ming Zhu Xu
16,624,325NT$208.6m0%no data
1.81%
Shin-Yi Enterprise Co., Ltd.
12,993,083NT$163.1m0%no data
1.7%
The Vanguard Group, Inc.
12,200,704NT$153.1m0%no data
0.8%
BlackRock, Inc.
5,714,131NT$71.7m0.42%no data
0.44%
Norges Bank Investment Management
3,130,237NT$39.3m0%no data
0.089%
State Street Global Advisors, Inc.
641,000NT$8.0m0%no data
0.052%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
374,000NT$4.7m0%no data
0.0091%
Gaoxiang Investment Co., Ltd.
65,000NT$815.3k0%no data